Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib
IMAGE 06/2020
Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib in R/R FL
Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib in R/R FL